JP2020531521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020531521A5 JP2020531521A5 JP2020511255A JP2020511255A JP2020531521A5 JP 2020531521 A5 JP2020531521 A5 JP 2020531521A5 JP 2020511255 A JP2020511255 A JP 2020511255A JP 2020511255 A JP2020511255 A JP 2020511255A JP 2020531521 A5 JP2020531521 A5 JP 2020531521A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- pharmaceutical composition
- amino acid
- concentration
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762548772P | 2017-08-22 | 2017-08-22 | |
| US62/548,772 | 2017-08-22 | ||
| PCT/US2018/047502 WO2019040608A1 (en) | 2017-08-22 | 2018-08-22 | PHARMACEUTICAL COMPOSITIONS AND DOSAGE SCHEMES CONTAINING ANTI-ALPHA (V) BETA ANTIBODIES (6) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020531521A JP2020531521A (ja) | 2020-11-05 |
| JP2020531521A5 true JP2020531521A5 (enExample) | 2021-09-30 |
Family
ID=63452750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020511255A Pending JP2020531521A (ja) | 2017-08-22 | 2018-08-22 | 抗アルファ（ｖ）ベータ（６）抗体を含有する医薬組成物及び投薬計画 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210363259A1 (enExample) |
| EP (1) | EP3672632A1 (enExample) |
| JP (1) | JP2020531521A (enExample) |
| KR (1) | KR20200044066A (enExample) |
| CN (1) | CN111201036A (enExample) |
| AU (1) | AU2018322475A1 (enExample) |
| BR (1) | BR112020003498A2 (enExample) |
| CA (1) | CA3073286A1 (enExample) |
| MA (1) | MA49948A (enExample) |
| MX (1) | MX2020001851A (enExample) |
| WO (1) | WO2019040608A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI884192B (zh) | 2019-12-05 | 2025-05-21 | 美商西健公司 | 抗αＶβ６抗體及抗體-藥物結合物 |
| WO2026011013A1 (en) | 2024-07-02 | 2026-01-08 | Epibiologics, Inc. | Binding agents and uses thereof |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| US6267958B1 (en) * | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
| US20020004482A1 (en) | 1997-08-08 | 2002-01-10 | Xiaozhu Huang | Treatment of acute lung injury and fibrosis with antagonists of avbeta6 |
| HRP20050934B1 (hr) * | 2003-04-04 | 2014-09-26 | Genentech, Inc. | Formulacije s visokom koncentracijom antitijela i proteina |
| NZ554520A (en) * | 2004-10-22 | 2010-03-26 | Amgen Inc | Methods for refolding of recombinant antibodies |
| GT200600031A (es) * | 2005-01-28 | 2006-08-29 | Formulacion anticuerpo anti a beta | |
| CN102875681A (zh) * | 2005-07-08 | 2013-01-16 | 拜奥根Idec马萨诸塞公司 | 抗-αvβ6抗体及其用途 |
| US8945564B2 (en) * | 2006-04-21 | 2015-02-03 | Novartis Ag | Antagonist anti-CD40 antibody pharmaceutical compositions |
| CA2665885A1 (en) * | 2006-10-19 | 2008-12-04 | The Regents Of The University Of California | Treatment and prevention of chronic asthma using antagonists of integrin .alpha.nu.beta.6 |
| EP2114451A2 (en) * | 2007-01-09 | 2009-11-11 | Wyeth a Corporation of the State of Delaware | Anti-il-13 antibody formulations and uses thereof |
| PE20091174A1 (es) * | 2007-12-27 | 2009-08-03 | Chugai Pharmaceutical Co Ltd | Formulacion liquida con contenido de alta concentracion de anticuerpo |
| CN107496917B (zh) * | 2010-02-26 | 2021-06-11 | 诺沃—诺迪斯克有限公司 | 包含稳定抗体的组合物 |
| CN103501825B (zh) * | 2011-05-02 | 2017-03-15 | 免疫医疗公司 | 用于小体积施用的同种异型选择的抗体的超滤浓缩 |
| MX2013013752A (es) * | 2011-05-25 | 2014-08-01 | Intermune Inc | Pirfenidona y tratamiento anti-fibrotico en pacientes seleccionados. |
| IL312865B2 (en) * | 2013-09-11 | 2025-06-01 | Eagle Biologics Inc | Liquid protein formulations containing viscosity-lowering agents |
| EP3383435A4 (en) * | 2015-11-30 | 2019-07-10 | Medimmune, LLC | OPTIMIZED RATES OF AMINO ACIDS AND SUGARS AS AMORPHOUS STABILIZING COMPOUNDS IN PHARMACEUTICAL COMPOSITIONS HAVING HIGH CONCENTRATIONS IN PROTEIN-BASED THERAPEUTICS |
-
2018
- 2018-08-22 BR BR112020003498-3A patent/BR112020003498A2/pt not_active IP Right Cessation
- 2018-08-22 JP JP2020511255A patent/JP2020531521A/ja active Pending
- 2018-08-22 MX MX2020001851A patent/MX2020001851A/es unknown
- 2018-08-22 WO PCT/US2018/047502 patent/WO2019040608A1/en not_active Ceased
- 2018-08-22 EP EP18762993.6A patent/EP3672632A1/en not_active Withdrawn
- 2018-08-22 KR KR1020207008234A patent/KR20200044066A/ko not_active Ceased
- 2018-08-22 CN CN201880065802.7A patent/CN111201036A/zh active Pending
- 2018-08-22 MA MA049948A patent/MA49948A/fr unknown
- 2018-08-22 AU AU2018322475A patent/AU2018322475A1/en not_active Abandoned
- 2018-08-22 CA CA3073286A patent/CA3073286A1/en not_active Abandoned
- 2018-08-22 US US16/640,422 patent/US20210363259A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12544438B2 (en) | Pharmaceutical products and stable liquid compositions of IL-17 antibodies | |
| JP2019523295A5 (enExample) | ||
| JP2008528638A5 (enExample) | ||
| AU2015313827C1 (en) | Use of IL-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients | |
| JP2020531520A5 (enExample) | ||
| RU2014117510A (ru) | Лечение ревматоидного артрита | |
| US20250011416A1 (en) | Methods for the treatment of cardiovascular disease | |
| JP2020531521A5 (enExample) | ||
| EP4192860A1 (en) | Sars-cov-2 antibodies for treatment and prevention of covid-19 | |
| WO2017076804A1 (en) | Treatment paradigm | |
| JPWO2020243031A5 (enExample) | ||
| WO2023240031A1 (en) | Compositions and methods for treating postural tachycardia syndrome | |
| IL292493B1 (en) | Stable aqueous anti-TFPI antibody formulation | |
| TW201828984A (zh) | 使用介白素-17(il-17)拮抗劑治療痤瘡的方法 | |
| JP2025536574A (ja) | 抗ｃｔｌａ抗体組成物及び関連方法 | |
| WO2025255300A1 (en) | FORMULATIONS FOR ANTI-N3pGlu AMYLOID BETA ANTIBODIES | |
| HK40108489A (en) | Pharmaceutical products and stable liquid compositions of il-17 antibodies | |
| WO2025072725A1 (en) | Methods for the treatment of cardiovascular disease | |
| WO2026024319A1 (en) | Treatment of obesity and obstructive sleep apnea | |
| RU2021129295A (ru) | Фармацевтические композиции, содержащие антитела к lingo-1 | |
| JPWO2020185750A5 (enExample) | ||
| HK1237260A1 (en) | Pharmaceutical products and stable liquid compositions of il-17 antibodies | |
| JPWO2022046942A5 (enExample) | ||
| JPWO2023073441A5 (enExample) |